Sui (SUI) is trading near a critical technical support level as bearish price pressure persists despite rapid growth across its decentralized finance ecosystem. Sui (SUI) is trading near a critical technical support level as bearish price pressure persists despite rapid growth across its decentralized finance ecosystem. 

SUI Near Critical Channel Floor With $2.90 Recovery Level in Focus

3 min read

Sui (SUI) is trading near a critical technical support level as bearish price pressure persists despite rapid growth across its decentralized finance ecosystem. 

As of Friday, January 30, SUI is hovering near the lower boundary of a descending price channel, a zone closely watched by traders for signs of either stabilization or further downside.

According to crypto analyst Ali, the latest price movements may indicate that selling pressure is easing, and buyers are stepping in to support the level. 

This is because a consolidation phase at the support of a descending channel is a potential inflection point for the asset. Therefore, it is a very important level for its next direction in an uncertain market.

Source: Ali X Post

If SUI is able to sustain above the current support level, the price may experience a relief bounce towards the $1.80 resistance area, which is also the midpoint of the channel. 

Breaking and sustaining above this level may allow the price to target the upper resistance of the channel around the $2.90 level. 

Failure to sustain the support level may see the price continuing to face downward pressure, with the bears maintaining control over the price momentum.

Also Read: SUI Volatility Rises as TVL Surpasses $920M and Support Levels Tighten

Technical Indicators Signal Continued Bearish Control

According to data from TradingView, as of Friday, January 30, SUI appears to be stuck in a correction period due to its inability to rise above the Ichimoku Cloud. 

This is because the price continues to stay below the Kumo, and the Tenkan-sen and Kijun-sen slopes are both trending downwards. There have also been rejections at the price range of $1.50 to $1.64, which have established this price range as a resistance zone.

Source: TradingView

Momentum indicators also reinforce the downside bias. The Relative Strength Index is currently around 29. This puts the asset in the oversold zone. The selling pressure on it has been strong. 

The MACD indicator is still negative, as the MACD line and the signal line are still below zero. The histogram is also declining. A major trend change may require the token to move back to the Ichimoku cloud. If SUI does not manage to stabilize, it may fall to the $1.10 support.

Sui TVL Surpasses $2B as Privacy-Focused DeFi Expands

Despite the short-term price pressures, the on-chain strength of Sui continues to improve. The Sui blockchain has now surpassed the $2 billion TVL mark, doubling its TVL within a period of 90 days.

This makes the blockchain one of the fastest-growing Layer 1s. Data highlighted by Altcoin Buzz on Friday, January 30, showed the increase in TVL was a result of an increase in DeFi participation.

One major contributor to this growth is Sui’s protocol-level zero-knowledge privacy solution, which offers private, confidential, and transparent transactions. This helps in addressing the issues of financial institutions regarding transparency. 

With increased global regulation of digital assets, the asset’s solution is now being perceived as a new opportunity for financial institutions such as banks and funds to enter financial services in a blockchain environment.

Also Read: SUI Slips to $1.30: Power Moves in ETF Market Could Spark $1.70 Bounce

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29